(Q37185460)

18 August 2017

1 reference

title

Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells (English)

1 reference

18 August 2017

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

10 December 2022

main subject

adoptive immunotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1853786

10 December 2022

author name string

P. D. Greenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1853786

10 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1853786

10 December 2022

publication date

1 January 1991

1 reference

18 August 2017

Advances in Immunology

1 reference

18 August 2017

49

1 reference

18 August 2017

281-355

1 reference

The Cell Biology of Macrophage Activation

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Peptide competition for antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen presentation by resting B cells. Radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Prospects for monoclonal antibody therapy of leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of the implanted tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Factors influencing antibody-mediated cytotoxicity during the immunotherapy of Rauscher-virus-induced myeloid leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Protein antigenic structures recognized by T cells: potential applications to vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen processing for presentation to T lymphocytes: function, mechanisms, and implications for the T-cell repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Regulation of the macrophage content of neoplasms by chemoattractants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Isolation and characterization of antigen-la complexes involved in T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The interaction between protein-derived immunogenic peptides and Ia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

T cell clones specific for an amphipathic alpha-helical region of sperm whale myoglobin show differing fine specificities for synthetic peptides. A multiview/single structure interpretation of immunodominance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Protection against syngeneic lymphoma by a long-lived cytotoxic T-cell clone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Interactions between macrophages and T-lymphocytes: tumor sneaking through intrinsic to helper T cell dynamics.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen-Reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Monoclonal antibodies for treating cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Dissection of an inflammatory process induced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Use of dimethylmyleran in adoptive chemoimmunotherapy of two murine leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Characterization of IL-2-induced murine cells which exhibit ADCC activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Interferon gamma and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Lymphotoxin cytotoxicity, a combination of cytolytic and cytostatic cellular responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Macrophages and neoplasms: new insights and their implication in tumor immunobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Models for syngeneic adoptive chemoimmunotherapy of murine leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Immunology: The ins and outs of antigen processing and presentations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Exclusive involvement of H-2D(b) or H-2K(d) product in the interaction between T-killer lymphocytes and syngeneic H-2(b) or H-2(d) viral lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Immunoregulatory T-cell pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Mechanism of cytotoxicity by natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Discrimination Between Neoplastic and Non-Neoplastic Cells In Vitro by Activated Macrophages12

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Possible role of anti-idiotypic antibodies in the induction of tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

1 reference

7 January 2021

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Establishment of monoclonal anti-Nk-1.1 antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigenicity of murine skin tumors induced by ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen-specific interaction between T and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Role of interleukin 1 in the activation of T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen presenting function of class II MHC expressing pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Fatal Epstein-Barr-Virus-Associated Proliferation of Donor B Cells After Treatment of Acute Graft-Versus-Host Disease with a Murine Anti-T-Cell Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The role of intracellular acidification in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Acquired resistance to Listeria monocytogenes is mediated by Lyt-2+ T cells independently of the influx of monocytes into granulomatous lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Vaccinia virus expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

An immunological basis for inhibition of transformation of human lymphocytes by EB virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Clonal analysis of cytotoxic T cell response against human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antitumor effects of hydrogen peroxide in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Anti-idiotypic antibodies and the induction of specific tumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cloned protein antigen-specific, Ia-restricted T cells with both helper and cytolytic activities: mechanisms of activation and killing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Emergence of a B lymphocyte population with ADCC effector function in mammary tumor bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

1 reference

7 January 2021

Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Interferon modulation of natural killer cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. 5. Role of proteases, inhibitors, and substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. II. Anti-mu treatment affects the initiation and recruitment of T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Regulation of protein export from the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cellular interactions resulting in skin-allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Internal Disintegration Model of Cytotoxic Lymphocyte-Induced Target Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2+ T cell subset

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

CD4+ helper T cells are required for resistance to a highly metastatic murine tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Unique tumor-specific antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Functional identity between murine γ Interferon and macrophage activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Acquisition of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Immunosuppressive activity of the retroviral envelope protein P 15E and its possible relationship to neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

An inhibitor of macrophage chemotaxis produced by neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The Lyt phenotype of a long-term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Role of the major histocompatibility complex class I antigens in tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognatevs. noncognate interactions in cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen recognition by class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Biology of natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen-Presenting Function of the Macrophage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The basis for the immunoregulatory role of macrophages and other accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Presence on a human melanoma of multiple antigens recognized by autologous CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen presentation by supported planar membranes containing affinity-purified I-Ad

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The biochemistry of antigen-specific T-cell factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Antigen-driven helper cell-independent cloned cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

The rate of bulk flow from the endoplasmic reticulum to the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Evidence for an involvement of T4+ cytotoxic T cells in tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Mediation of in vivo tumor-neutralizing activity by Lyt-2+ as well as L3T4+ T cell subsets.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Cell-mediated killing: a common mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Genetic control of the immune response to Thy-1 antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Nuclear disintegration of target cells by killer B lymphocytes from tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic cells and B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Ly-1+2- suppressor T cells inhibit the expression of passively transferred antitumor immunity by suppressing the generation of cytolytic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Idiotype Network Interactions in Tumor Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960778-6

7 January 2021

Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors

2

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases

10 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

The interplay of lymphoid cells and macrophages in tumour immunity

10 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Cationization of protein antigens. IV. Increased antigen uptake by antigen-presenting cells

10 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells

10 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide

10 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Specificity of adoptive chemoimmunotherapy of established syngeneic tumors

10 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones

10 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens

10 December 2022

53

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Split tolerance affecting delayed hypersensitivity and induced in mice by pre-immunization with protein antigens in solution

10 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages

10 December 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Adoptive immunotherapy of syngeneic murine leukemia is enhanced by the combination of recombinant IFN-gamma and a tumor-specific cytotoxic T cell clone

10 December 2022

59

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Influence of antibody isotype on passive serotherapy of lymphoma

10 December 2022

60

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Sufficiency of the CD8+ T cell lineage to mount an effective tumoricidal response to syngeneic tumor-bearing novel class I MHC antigens

10 December 2022

82

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin

10 December 2022

95

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Recognition of an Igh-linked histocompatibility antigen, H-40, on B-cell tumors by cytotoxic T lymphocytes

10 December 2022

96

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice

10 December 2022

99

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts

10 December 2022

100

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity

10 December 2022

101

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones

10 December 2022

102

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts

10 December 2022

104

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens

10 December 2022

107

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia

10 December 2022

115

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells

10 December 2022

116

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Detection of early and delayed antitumor effects following curative adoptive chemoimmunotherapy of established leukemia

10 December 2022

118

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Immunologic reactivity of lymphoid cells in tumors

10 December 2022

132

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells

10 December 2022

137

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Enhancement of in vivo cell-mediated immune responses by three distinct cytokines

10 December 2022

142

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities

10 December 2022

150

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

The NK-1.1(-) mouse: a model to study differentiation of murine NK cells

10 December 2022

166

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Priming and triggering of tumoricidal and schistosomulicidal macrophages by two sequential lymphokine signals: interferon-gamma and macrophage cytotoxicity inducing factor 2

10 December 2022

167

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells

10 December 2022

171

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts

10 December 2022

177

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Modification of host antitumor defense mechanisms in mice by progressively growing tumor

10 December 2022

183

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

A limited region within hen egg-white lysozyme serves as the focus for a diversity of T cell clones

10 December 2022

184

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor

10 December 2022

185

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction

10 December 2022

186

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation

10 December 2022

194

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Murine monoclonal IgG3 to human colorectal tumor-associated antigens: enhancement of antibody-dependent cell-mediated cytotoxicity by interleukin 2

10 December 2022

206

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins

10 December 2022

210

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

T cell-mediated suppression of the concomitant antitumor immune response as an example of transplantation tolerance

10 December 2022

225

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells

10 December 2022

233

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing

10 December 2022

236

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserum

10 December 2022

242

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Do tumors grow because of the immune response of the host?

10 December 2022

252

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Analysis of the idiotypic network in tumor immunity

10 December 2022

254

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations

10 December 2022

270

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor

10 December 2022

271

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities

10 December 2022

274

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Adjuvant chemoimmunotherapy of cancer: influence of tumor burden and role of functional immune effector cells in mice

10 December 2022

280

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells

10 December 2022

294

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2

10 December 2022

307

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Escape mechanisms of melanoma from immune system by soluble melanoma antigen

10 December 2022

311

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity

10 December 2022

319

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

10 December 2022

321

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro

10 December 2022

326

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60778-6

10 December 2022

Identifiers

0 references

1 reference